MedPath

武邑慈航药业有限公司

Ownership
-
Established
2000-08-12
Employees
-
Market Cap
-
Website
www.cihangyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Fasudil Hydrochloride

Product Name
盐酸法舒地尔
Approval Number
国药准字H20123032
Approval Date
May 9, 2022
NMPA

Probucol

Product Name
普罗布考
Approval Number
国药准字H10960292
Approval Date
Sep 29, 2020
NMPA

Benorilate

Product Name
贝诺酯
Approval Number
国药准字H13023175
Approval Date
Sep 29, 2020
NMPA

Aspirin

Product Name
阿司匹林
Approval Number
国药准字H20053320
Approval Date
Sep 29, 2020
NMPA

Oxiracetam

Product Name
奥拉西坦
Approval Number
国药准字H20143240
Approval Date
Jun 25, 2019
NMPA

Olopatadine Hydrochloride

Product Name
盐酸奥洛他定
Approval Number
国药准字H20080460
Approval Date
May 2, 2018
NMPA

Levamlodipine Besylate

Product Name
苯磺酸左氨氯地平
Approval Number
国药准字H20083171
Approval Date
Mar 16, 2018
NMPA

Tamsulosin Hydrochloride

Product Name
盐酸坦洛新
Approval Number
国药准字H20083161
Approval Date
Apr 15, 2013
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.